Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 14370-14371 [2023-04700]
Download as PDF
<![CDATA[
14370
Federal Register / Vol. 88, No. 45 / Wednesday, March 8, 2023 / Notices
Comments will be used in the
formulation of the final real property
management business standards.
FOR FURTHER INFORMATION CONTACT:
Krystal J. Brumfield,
Associate Administrator, Office of
Government-wide Policy, General Services
Administration.
[FR Doc. 2023–04679 Filed 3–7–23; 8:45 am]
BILLING CODE 6820–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
lotter on DSK11XQN23PROD with NOTICES1
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—RFA–PS23–
002, Enhancing Telehealth Strategies
To Support Retention and Adherence
to Antiretroviral Therapy (ART) and
RFA–PS23–005, Expanding Rapid
Initiation of Antiretroviral Therapy in
Non-Traditional Settings: Emergency
Department; Amended Notice of
Closed Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—RFA–
PS23–002, Enhancing Telehealth
Strategies to Support Retention and
Adherence to Antiretroviral Therapy
(ART) and RFA–PS23–005, Expanding
Rapid Initiation of Antiretroviral
Therapy in Non-traditional Settings:
Emergency Department, May 24–25,
2023, 10 a.m.–5 p.m., EDT,
Teleconference, Centers for Disease
Control and Prevention, Room 1077, 8
Corporate Blvd., Atlanta, GA 30329, in
the original FRN. The meeting was
published in the Federal Register on
February 13, 2023, Volume 88, Number
29, page/s/ 9290.
The meeting is being amended to
remove RFA–PS23–005, Expanding
Rapid Initiation of Antiretroviral
Therapy in Non-traditional Settings:
Emergency Department and replace
with RFA–PS23–003, Exploring
Preferences for Long-Acting
Antiretroviral Therapies (LA–ART) in a
Community-Based Sample of Priority
Populations Living with HIV Who are
Disproportionately Affected and the
date the teleconference is has changed
and should read as follows:
Date: May 11–12, 2023.
Time: 10 a.m.–5 p.m. (EDT).
Place: Teleconference, Centers for
Disease Control and Prevention, Room
1077, 8 Corporate Blvd., Atlanta, GA
30329.
The meeting is closed to the public.
VerDate Sep<11>2014
16:48 Mar 07, 2023
Jkt 259001
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, CDC, 1600 Clifton
Road NE, Mailstop US8–1, Atlanta,
Georgia 30329, Telephone: (404) 718–
8833; Email: GAnderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–04698 Filed 3–7–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The CDC announces the
following meeting of the Advisory
Board on Radiation and Worker Health
(ABRWH or the Advisory Board). This
meeting is open to the public, limited
only by the space available and without
a public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcomed to
listen to the meeting by joining the
audio conference (information below).
The audio conference line has 150 ports
for callers.
DATES: The meeting will be held on
April 19, 2023, from 1 p.m. to 4 p.m.,
EDT and on April 20, 2023, from 1 p.m.
to 4 p.m., EDT. Written comments must
be received on or before April 12, 2023.
ADDRESSES: You may submit comments
by mail to: Rashaun Roberts, National
Institute for Occupational Safety and
Health (NIOSH), CDC, 1090 Tusculum
SUMMARY:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Avenue, Mailstop C–24, Cincinnati,
Ohio 45226.
Meeting Information: The USA tollfree dial-in numbers are: +1 669 254
5252 US (San Jose); +1 646 828 7666 US
(New York). The Meeting ID is: 161 420
2917 and the Passcode is: 23289352;
Web conference by Zoom meeting
connection: https://cdc.zoomgov.com/j/
1614202917?pwd=UjhiSmpMd2RzS2kx
TXRmUDUzNU1BQT09.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone
(513) 533–6800, Toll Free 1(800) CDC–
INFO, Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, renewed at
appropriate intervals, and rechartered
under Executive Order 13889 on March
22, 2022, and will terminate on March
22, 2024.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
E:\FR\FM\08MRN1.SGM
08MRN1
Federal Register / Vol. 88, No. 45 / Wednesday, March 8, 2023 / Notices
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Considered: The agenda
will include discussions on the
following: NIOSH Program Update;
Department of Labor Program Update;
Department of Energy Program Update;
SEC Petitions Update; Procedures
Review Finalization/Document
Approvals; Savannah River Site
Workgroup Update, and a Board Work
Session. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
(Authority: 5 U.S.C. 1001 et. seq.)
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–04700 Filed 3–7–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2023–0015; NIOSH 278]
Board of Scientific Counselors,
National Institute for Occupational
Safety and Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention announces the
following meeting of the Board of
Scientific Counselors, National Institute
for Occupational Safety and Health
(BSC, NIOSH). This is a virtual meeting.
It is open to the public, limited only by
the number of web conference lines (500
web conference lines are available).
Time will be available for public
comment.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
The meeting will be held on
April 21, 2023, from 10 a.m. to 3 p.m.,
EDT.
DATES:
VerDate Sep<11>2014
16:48 Mar 07, 2023
Jkt 259001
Written comments must be received
on or before April 14, 2023.
ADDRESSES: If you wish to attend the
meeting, please register at the NIOSH
website at https://www.cdc.gov/niosh/
bsc/ or by telephone at (202) 245–0649
no later than April 14, 2023.
You may submit comments, identified
by Docket No. CDC–2023–0015;
NIOSH–278 by either of the methods
listed below. CDC does not accept
comments by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Ms. Sherri Diana, NIOSH
Docket Office, National Institute for
Occupational Safety and Health, 1090
Tusculum Avenue, Mailstop C–34,
Cincinnati, Ohio 45226. Attn: Docket
No. CDC–2023–0015; NIOSH–278.
Instructions: All submissions received
must include the Agency name and
docket number. Docket number CDC–
2023–0015; NIOSH–278 will close April
14, 2023.
FOR FURTHER INFORMATION CONTACT:
Maria Strickland, M.P.H., Designated
Federal Officer, BSC, NIOSH, CDC,
Patriots Plaza 1, 395 E Street SW, Suite
9200, Washington, DC 20201;
Telephone: (202) 245–0649; Email:
MStrickland2@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Secretary of Health
and Human Services, the Assistant
Secretary for Health, and by delegation
the Director, Centers for Disease Control
and Prevention, are authorized under
Sections 301 and 308 of the Public
Health Service Act to conduct directly,
or by grants or contracts, research,
experiments, and demonstrations
relating to occupational safety and
health and to mine health.
Purpose: The Board of Scientific
Counselors, National Institute for
Occupational Safety and Health (BSC,
NIOSH) provides advice to the Director,
National Institute for Occupational
Safety and Health, on NIOSH research
and prevention programs. The Board
also provides guidance on the Institute’s
research activities related to developing
and evaluating hypotheses,
systematically documenting findings,
and disseminating results. In addition,
the Board evaluates the degree to which
the activities of NIOSH: (1) conform to
those standards of scientific excellence
appropriate for federal scientific
institutions in accomplishing objectives
in occupational safety and health; (2)
address currently relevant needs in the
fields of occupational safety and health
either alone or in conjunction with
other known activities inside and
outside of NIOSH; and (3) produce their
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
14371
intended results in addressing
important research questions in
occupational safety and health, both in
terms of applicability of the research
findings and dissemination of the
findings.
Matters to be Considered: The agenda
for the meeting addresses Per- and
Polyfluoroalkyl Substances and
Occupational Safety and Health
Economics. Agenda items are subject to
change as priorities dictate.
The agenda is also posted on the
NIOSH website at https://www.cdc.gov/
niosh/bsc/.
Public Participation
Written Public Comment: Written
comments will be accepted per the
instructions provided in the addresses
section above. Comments received in
advance of the meeting are part of the
public record and are subject to public
disclosure. Written comments will be
included in the official record of the
meeting. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near-duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written comments received by April
14, 2023, will be provided to the Board
prior to the meeting.
Oral Public Comment: The public is
welcome to participate during the
public comment period, from 1:30 p.m.
to 1:45 p.m., EDT, April 21, 2023. Each
commenter will be provided up to five
minutes for comment. A limited number
of time slots are available and will be
assigned on a first-come, first-served
basis. Members of the public who wish
to address the BSC, NIOSH are
requested to contact the Designated
Federal Officer for scheduling purposes
(see FOR FUTHER INFORMATION CONTACT
above).
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\08MRN1.SGM
08MRN1
]]>Agencies
[Federal Register Volume 88, Number 45 (Wednesday, March 8, 2023)]
[Notices]
[Pages 14370-14371]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04700]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH), National
Institute for Occupational Safety and Health (NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The CDC announces the following meeting of the Advisory Board
on Radiation and Worker Health (ABRWH or the Advisory Board). This
meeting is open to the public, limited only by the space available and
without a public comment period. The public is welcome to submit
written comments in advance of the meeting, to the contact person
below. Written comments received in advance of the meeting will be
included in the official record of the meeting. The public is also
welcomed to listen to the meeting by joining the audio conference
(information below). The audio conference line has 150 ports for
callers.
DATES: The meeting will be held on April 19, 2023, from 1 p.m. to 4
p.m., EDT and on April 20, 2023, from 1 p.m. to 4 p.m., EDT. Written
comments must be received on or before April 12, 2023.
ADDRESSES: You may submit comments by mail to: Rashaun Roberts,
National Institute for Occupational Safety and Health (NIOSH), CDC,
1090 Tusculum Avenue, Mailstop C-24, Cincinnati, Ohio 45226.
Meeting Information: The USA toll-free dial-in numbers are: +1 669
254 5252 US (San Jose); +1 646 828 7666 US (New York). The Meeting ID
is: 161 420 2917 and the Passcode is: 23289352; Web conference by Zoom
meeting connection: https://cdc.zoomgov.com/j/1614202917?pwd=UjhiSmpMd2RzS2kxTXRmUDUzNU1BQT09.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24,
Cincinnati, Ohio 45226, Telephone (513) 533-6800, Toll Free 1(800) CDC-
INFO, Email [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule, advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC). In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC.
The Advisory Board's charter was issued on August 3, 2001, renewed
at appropriate intervals, and rechartered under Executive Order 13889
on March 22, 2022, and will terminate on March 22, 2024.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their
[[Page 14371]]
radiation dose, and on whether there is reasonable likelihood that such
radiation doses may have endangered the health of members of this
class.
Matters to be Considered: The agenda will include discussions on
the following: NIOSH Program Update; Department of Labor Program
Update; Department of Energy Program Update; SEC Petitions Update;
Procedures Review Finalization/Document Approvals; Savannah River Site
Workgroup Update, and a Board Work Session. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
(Authority: 5 U.S.C. 1001 et. seq.)
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04700 Filed 3-7-23; 8:45 am]
BILLING CODE 4163-18-P
